New radiation method aims to boost survival in tough-to-treat leukemia patients
NCT ID NCT03121014
First seen Jan 19, 2026 · Last updated Apr 29, 2026 · Updated 11 times
Summary
This study tests whether adding a precise, high-dose radiation to the whole marrow before a stem cell transplant can help people with high-risk acute myeloid leukemia or myelodysplastic syndromes live longer without their cancer coming back. About 38 adults aged 18-65 will receive the extra radiation along with standard chemotherapy before the transplant. The goal is to see if this approach improves relapse-free survival at one year.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Illinois at Chicago
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.